Nuveen New Jersey Quality Municipal Income Fund (New York Stock Exchange:NXJ)
| Market Cap | $511.70M+9.5% |
| Revenue (ttm) | $18.58M+105.4% |
| Net Income | $3.68M+5742.3% |
| EPS | $0.09+5770.4% |
| Shares Out | 41.23M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | $0.47(3.80%) |
| Ex-Dividend Date | Apr 15, 2026 |
| Volume | 113,134 |
| Open | $12.40 |
| Previous Close | $12.39 |
| Day's Range | $12.37 - $12.44 |
| 52-Week Range | $11.06 - $12.90 |
| Beta | 0.66 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | n/a |
About NXJ
Nuveen New Jersey Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New Jersey. The fund invests in undervalued municipal securities and other related investments that are, exempt from regular federal and New Jersey income taxes that are rated Baa or BBB or better. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor’s (S&P) New Jersey Municipal Bond Index. The fund was formerly known as Nuveen New Jersey Dividend Advantage Municipal Fund. Nuveen New Jersey Quality Municipal Income Fund was formed on June 1, 1999 and is domiciled in the United States.
$NXJ stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in NXJ holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NXJ's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NXJ Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NXJ patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NXJ from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from NXJ’s recent data — informational, not investment advice